NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 240 filers reported holding NEOGENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,657,833 | +115107.3% | 165,391 | +24.8% | 0.03% | -11.1% |
| Q1 2023 | $2,307 | +118.7% | 132,502 | +16.0% | 0.04% | +71.4% |
| Q4 2022 | $1,055 | -99.8% | 114,209 | +106.0% | 0.02% | +110.0% |
| Q3 2022 | $477,000 | +58.5% | 55,430 | +123.8% | 0.01% | +42.9% |
| Q1 2022 | $301,000 | -43.3% | 24,768 | +125.2% | 0.01% | -36.4% |
| Q1 2021 | $531,000 | -45.9% | 11,000 | -85.9% | 0.01% | -42.1% |
| Q4 2018 | $982,000 | +42.1% | 77,896 | +73.1% | 0.02% | +11.8% |
| Q3 2018 | $691,000 | +26.8% | 45,012 | +8.4% | 0.02% | -10.5% |
| Q2 2018 | $545,000 | +306.7% | 41,542 | +153.6% | 0.02% | +375.0% |
| Q1 2018 | $134,000 | -62.8% | 16,380 | -64.1% | 0.00% | -63.6% |
| Q1 2017 | $360,000 | +56.5% | 45,632 | +69.8% | 0.01% | +83.3% |
| Q4 2016 | $230,000 | +155.6% | 26,870 | +145.5% | 0.01% | +200.0% |
| Q3 2016 | $90,000 | -21.1% | 10,943 | -22.8% | 0.00% | 0.0% |
| Q2 2016 | $114,000 | – | 14,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,516,313 | $14,011 | 8.43% |
| Greenhouse Funds LLLP | 2,795,231 | $25,827,934 | 2.36% |
| First Light Asset Management, LLC | 2,682,171 | $24,783,260 | 2.30% |
| PERKINS CAPITAL MANAGEMENT INC | 197,700 | $1,827 | 1.93% |
| Altium Capital Management LP | 285,000 | $2,633,400 | 1.34% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,654,543 | $15,287,977 | 0.95% |
| EMERALD ADVISERS, LLC | 2,101,567 | $19,418,479 | 0.94% |
| Bullseye Asset Management LLC | 105,997 | $980 | 0.53% |
| OAK FAMILY ADVISORS, LLC | 101,194 | $935,033 | 0.50% |
| FORMULA GROWTH LTD | 180,300 | $1,665,972 | 0.47% |